Dennis E. Marshall - 26 Dec 2024 Form 4 Insider Report for BIOLARGO, INC. (BLGO)

Role
Director
Signature
/s/ John R. Browning, attorney-in-fact
Issuer symbol
BLGO
Transactions as of
26 Dec 2024
Net transactions value
$0
Form type
4
Filing time
30 Dec 2024, 15:30:02 UTC
Previous filing
01 Oct 2024
Next filing
03 Jan 2025

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BLGO Option to Purchase Common Stock Award $0 +118,422 +2.7% $0.000000 4,525,941 26 Dec 2024 Common Stock 118,422 $0.1900 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This Option was granted to Reporting Person to replace an option to purchase 64,286 shares that had been issued to compensate Reporting Person for services to the Issuer and had recently expired unexercised due to a discrepancy between the original exercise price and current Issuer stock price, pursuant to plan adopted by the Issuer's Compensation Committee.
F2 Total reflects the expiration of options to purchase 64,286 shares that recently expired.